Daron Evans, President and CEO at NEPHROS INC (NEPH), bought 21,461 shares at $0.26 ($6K) on 2017-06-09, disclosed to the SEC on 2017-06-13.
Open-market purchase of $6k NEPH by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.26 | 7,500 | $2K | 34.9% |
| 2 | $0.26 | 10,000 | $3K | 46.6% |
| 3 | $0.26 | 3,961 | $1K | 18.5% |
| Total | $0.26 avg | 21,461 | $6K | 100% |
| Filing → |
| RZLT | BUY | 2025-06-24 | $20K | — | Filing → |
| RZLT | BUY | 2025-03-28 | $58K | — | Filing → |
| RZLT | BUY | 2024-12-18 | $43K | — | Filing → |